A. E. Lykkesfeldt

ABNORMAL ANDROGEN AND OESTROGEN METABOLISM IN MEN WITH STEROID SULPHATASE DEFICIENCY AND RECESSIVE X‐LINKED ICHTHYOSIS

Gert Lykkesfeldt, A. E. Lykkesfeldt, S. Mičić et al. · Clinical Endocrinology · 1985 · 105 citations

Phosphorylation of ERα at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERα phosphorylation in breast cancer progression

Naveed Sarwar, J. S. Kim, Jie Jiang et al. · Endocrine Related Cancer · 2006 · 100 citations · Full text

Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer.

Christina M.W. Chan, A. E. Lykkesfeldt, Malcolm G. Parker et al. · PubMed · 1999 · 45 citations

Breast Oncology, Cancer Biology, Tumor Biology +19

Dna Ploidy and S-Phase Fraction in Primary Breast Carcinomas in Relation to Prognostic Factors and Survival for Premenopausal Patients at High Risk for Recurrent Disease

A. E. Lykkesfeldt, I. Balslev, Ib Jarle Christensen et al. · Acta Oncologica · 1988 · 24 citations · Full text

Breast Oncology, Medicine, Primary Breast Carcinomas +10

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial

Bent Ejlertsen, Julie Aldridge, Kirsten Vang Nielsen et al. · Annals of Oncology · 2011 · 23 citations · Full text

Breast Oncology, Esr1 Status, Medicine +8